Farmers & Merchants Trust Co of Chambersburg PA Trims Position in Colfax Corp (CFX)

Share on StockTwits

Farmers & Merchants Trust Co of Chambersburg PA lowered its position in shares of Colfax Corp (NYSE:CFX) by 88.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,500 shares of the industrial products company’s stock after selling 18,775 shares during the period. Farmers & Merchants Trust Co of Chambersburg PA’s holdings in Colfax were worth $74,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Macquarie Group Ltd. bought a new stake in Colfax during the 4th quarter worth $27,000. Pinnacle Bank bought a new stake in shares of Colfax in the 4th quarter valued at about $36,000. SG Americas Securities LLC bought a new stake in shares of Colfax in the 4th quarter valued at about $112,000. Group One Trading L.P. bought a new stake in shares of Colfax in the 4th quarter valued at about $121,000. Finally, Citigroup Inc. grew its position in shares of Colfax by 457.7% in the 4th quarter. Citigroup Inc. now owns 8,065 shares of the industrial products company’s stock valued at $168,000 after buying an additional 6,619 shares during the last quarter. Institutional investors and hedge funds own 79.99% of the company’s stock.

In other news, SVP Lynn H. Clark sold 2,666 shares of the business’s stock in a transaction dated Tuesday, February 19th. The stock was sold at an average price of $26.50, for a total value of $70,649.00. Following the transaction, the senior vice president now directly owns 35,662 shares of the company’s stock, valued at approximately $945,043. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Ian Brander sold 4,260 shares of the business’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $27.01, for a total value of $115,062.60. Following the completion of the transaction, the chief executive officer now directly owns 21,876 shares in the company, valued at $590,870.76. The disclosure for this sale can be found here. 12.00% of the stock is owned by insiders.

Shares of NYSE:CFX opened at $30.43 on Tuesday. The stock has a market capitalization of $3.58 billion, a PE ratio of 13.13, a price-to-earnings-growth ratio of 0.94 and a beta of 1.58. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.22 and a current ratio of 1.63. Colfax Corp has a 1 year low of $18.95 and a 1 year high of $37.05.

Colfax (NYSE:CFX) last announced its quarterly earnings data on Wednesday, February 13th. The industrial products company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.06. The company had revenue of $985.00 million for the quarter, compared to the consensus estimate of $982.49 million. Colfax had a return on equity of 7.79% and a net margin of 3.82%. The firm’s revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 EPS. On average, equities research analysts forecast that Colfax Corp will post 2.6 EPS for the current fiscal year.

CFX has been the topic of a number of analyst reports. Zacks Investment Research reiterated a “buy” rating and issued a $22.00 price target on shares of Colfax in a research report on Monday, December 31st. Barclays upgraded Colfax from an “underweight” rating to an “equal weight” rating and set a $28.70 price target on the stock in a research report on Friday, March 15th. They noted that the move was a valuation call. Stifel Nicolaus reiterated a “buy” rating and issued a $31.00 price target on shares of Colfax in a research report on Wednesday, December 19th. Raymond James reiterated a “buy” rating and issued a $25.00 price target on shares of Colfax in a research report on Friday, February 22nd. Finally, Oppenheimer reiterated a “buy” rating on shares of Colfax in a research report on Thursday, February 14th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $31.51.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Macon Daily and is owned by of Macon Daily. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://macondaily.com/2019/04/16/farmers-merchants-trust-co-of-chambersburg-pa-trims-position-in-colfax-corp-cfx.html.

Colfax Profile

Colfax Corporation operates as a diversified technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, installs, and maintains heavy-duty fans, rotary heat exchangers, blowers, and compressors.

Recommended Story: What Are Cryptocurrencies?

Want to see what other hedge funds are holding CFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colfax Corp (NYSE:CFX).

Institutional Ownership by Quarter for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.